Wolverine Trading, LLC Novo Nordisk A S Transaction History

Wolverine Trading, LLC

$133 Billion
Q3 2025

A detailed history of Wolverine Trading, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wolverine Trading, LLC holds 9,629 shares of NVO stock, worth $466,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,629

Previous 65,045 85.2%

Holding current value

$466,621

Previous $4.49 Million 88.1%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$45.38 - $71.7 $2.51 Million - $3.97 Million	-55,416 Reduced 85.2%	9,629 $534,000
Q2 2025 Aug 18, 2025	BUY	$58.08 - $81.05 $3.78 Million - $5.27 Million	65,045 New	65,045 $4.49 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $2.71 Million - $3.82 Million	31,830 Added 165.96%	51,009 $4.39 Million
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $6.65 Million - $8.13 Million	-55,874 Reduced 74.45%	19,179 $2.28 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $4.39 Million - $5.25 Million	35,754 Added 90.98%	75,053 $10.7 Million

Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $2.49 Million - $3.31 Million	24,384 Added 163.49%	39,299 $5.05 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $146,417 - $175,890	1,668 Added 12.59%	14,915 $1.54 Million
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $607,115 - $1.33 Million	6,676 Added 101.6%	13,247 $1.2 Million
Q2 2023 Aug 23, 2023	BUY	$155.98 - $172.65 $378,875 - $419,366	2,429 Added 58.64%	6,571 $1.06 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $1.02 Million - $1.23 Million	-7,725 Reduced 65.1%	4,142 $655,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $923,360 - $1.22 Million	9,004 Added 314.5%	11,867 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $272,786 - $334,770	2,863 New	2,863 $287,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $591,771 - $722,617	-6,172 Reduced 74.65%	2,096 $234,000
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $559,412 - $700,795	8,268 New	8,268 $693,000
Q1 2020 May 11, 2020	SELL	$49.46 - $64.78 $278,113 - $364,257	-5,623 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$49.86 - $58.26 $292,728 - $342,044	-5,871 Reduced 51.08%	5,623 $325,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $153,982 - $173,059	3,239 Added 39.24%	11,494 $593,000
Q2 2019 Aug 20, 2019	BUY	$46.79 - $52.47 $99,148 - $111,183	2,119 Added 34.53%	8,255 $421,000
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $641,390 - $728,136	-13,835 Reduced 69.28%	6,136 $321,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $268,473 - $305,376	6,463 Added 47.85%	19,971 $915,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $43,019 - $47,140	920 Added 7.31%	13,508 $637,000
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $610,392 - $731,866	12,588 New	12,588 $620,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $414,271 - $468,310	-8,716 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$41.15 - $49.22 $358,663 - $429,001	8,716	8,716 $420,000

Others Institutions Holding NVO

# of Institutions

1,695

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Novo Nordisk A S Transaction History